Multinational Pharmaceutical Companies in India: Navigating Regulatory Challenges
Multinational pharmaceutical companies operating in India currently face several regulatory challenges stemming from the country’s evolving healthcare policy landscape, pricing regulations, intellectual property regime, and compliance expectations. The following are the core issues: Price Controls by NPPA Quoting source Businessdrugcontrol.org, as of March 25, 2025, ceiling prices have been fixed for 928 scheduled formulations, with […]